Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of FSH Dosage on Granulosa Cell Receptors
NCT05330130Phase 1Completed
- Sponsor
- ART Fertility Clinics
- Start
- Jul 2023
- Primary completion
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of follitropin beta in infertility (2 arms), sponsored by ART Fertility Clinics. Primary endpoints: Number of FSHR- and LHR of the GC, obtained from one follicle on the morning of day 5, Number of FSHR- and LHR of the GC, obtained from one follicle of the size of 12 to 14 mm and 2 more. Started Jul 2023; status: completed.
02
Drugs
follitropin beta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05330130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05330130.